Cytotoxicity on low-grade canine meningioma with the use of somatostatin analog (octreotide): An in vitro study.
Maria Teresa MandaraAlessia TognoloniGiuseppe GigliaMassimo BaroniCristian FalzonePietro CalòElisabetta ChiaradiaPublished in: Neuro-oncology advances (2024)
Octreotide reduced the alive neoplastic cultured cells of low-grade canine meningioma in a dose-dependent pattern with continuous exposition for 48 hours. These results support an alternative systemic treatment of meningioma with octreotide in the dog.